Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-17-020971

EVP, Chief Financial Officer acquired 5,583 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Burke Willaim P EVP, Chief Financial Officer 2017-06-06 Grant or award +5,583 $41.64 $232,476 15,996 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Burke Willaim P EVP, Chief Financial Officer 2017-06-06 Grant or award · Non-qualified Stock Option (Right to Buy) +22,870 $41.64 $952,307 22,870 D: show line 2 in the form
Loading xslF345X03/form4.xml…